Fig. 4

A landscape of immunomics: developmental tendency and future direction. a The timeline of immunomics technologies. b Historical development trajectory and future prospective of tumor immunomics. CODEX codetection by indexing, CyTOF cytometry by time-of-light, ESTIMATE estimation of stromal and immune cells in malignant tumors using expression data, GATK Genome Analysis Toolkit, GenomeVIP Genome Variant Investigation Platform, HDST high-definition spatial transcriptome, IMC imaging mass cytometry, MCP-counter microenvironment cell populations-counter, MIBI-TOF multiplexed ion beam imaging by time-of-flight, mIF multiplex immunofluorescence, mIHC multiplex immunohistochemistry